Professional Documents
Culture Documents
CBA : MR./Ms.
Date
Sep'14
1.4.2015
KATNI
KATNI
11
M H KHAN
2.4.2015
KATNI
KATNI
10
PRAVEEN VAISYA
3.4.2015
BARHI
BARHI
11
MRS H BATRA
4.4.2015
UMARIYA
UMARIYA
14
NEERESH JAIN
6.4.2015
TRANSIT
TRANSIT
7.4.2015
MEETING
MEETING
8.4.2015
MEETING
MEETING
9.4.2015
TRANSIT
TRANSIT
10.4.2015
KATNI
KATNI
13
11.4.2015
PALI
PALI
12
13.4.2015
SHAHDOL
SHAHDOL
12
14.4.2015
BURHAR
BURHAR
15.4.2015
SHAHDOL
SHAHDOL
16.4.2015
KATNI
KATNI
11
17.5.2015
KYMORE
KYMORE
11
18.4.2015
KATNI
KATNI
14
20.4.2015
BAKAL
KATNI
14
21.4.2015
KATNI
BAKAL
22.4.2015
BARHI
BARHI
11
23.4.2015
UMARIYA
UMARIYA
14
24.4.2015
KATNI
KATNI
14
25.4.2015
PALI
PALI
12
27.4.2015
SHAHDOL
SHAHDOL
14
28.4.2015
BURHAR
BURHAR
13
29.4.2015
SHAHDOL
KATNI
13
30.4.2015
KATNI
KATNI
11
260
133
TOTAL
F/WD:-
Oct'14
Nov'14
Tracker
MONTH: MR
No of Days in a month
Sundays/Holidays
No.of Days on leave
No.of days Conf/Meeting
No of Camps Day
Transit/Non working days
No.of days field work
No.of Doctor Calls
No.of Chemist Calls
Doctor Call Avg.
Chemist Call Avg.
No of Gold Drs met twice-(125 DRS)
No of Silver drs met ONCE-(25 DRS)
No of Drs missed
% of Dr.coverage
Compliance % as per AIMS
No of stockist/ met
POB (Rs.)
No of Days work with ABM
No Of Days work with MBD
No Of Days work with DBM/HO
April
30
4
0
2
0
2
22
260
133
11.82
6.05
112
25
5
97%
89%
5
26000
2
0
0
y
May
31
June
30
July
31
August
31
September
30
31
30
31
31
30
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
100%
100%
100%
100%
100%
OUTPUT PARAMETERS
Last year Primary
Target
Achievement
% Ach
Gr%
Sec
Expiry
Breakage/Damage
Sales return
Total (A+B+C)
% to sales
1.34
1.5
1.71
114.00 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!
27.61% #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!
1.45
0
0
0
0
0
0
0
0
0
0
###
###
###
###
###
October
31
November December
30
31
January
30
February
28
March
31
31
30
31
30
28
31
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
100%
100%
100%
100%
100%
100%
0
###
0
###
0
###
0
###
0
###
0
###
Domadol cap
Domadol Plus
Domadol 1 ml
Etoxib 120
Etoxib 60
Etoxib 90
Etoxib MR
Fineheal
Fineheal D
Fineheal Forte
PTS
104.05
104.05
104.05
104.05
48.85
48.85
48.85
48.85
39.09
39.09
39.09
39.09
46.79
46.79
46.79
46.79
76.80
76.80
76.80
76.80
42.00
42.00
42.00
42.00
58.80
58.80
58.80
58.80
103.28
103.28
103.28
103.28
106.83
106.83
106.83
106.83
109.71
109.71
109.71
109.71
205.71
Feb
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Mar
Apr
52
125
402
0
114
61
149
95
160
92
148
130
0
11
0
0
100
86
113
70
50
15
93
50
350
312
248
190
50
33
120
40
10
4
50
10
0
34
168
0
0
May
Fineheal Forte
Lanpro 15
Lanpro 30
M-Cam 7.5
M-Cam 15
Podplus 325
Podplus DS
Power D 3 1000
Power D 3 60K
Powercal
Pregaba M 150
205.71 Secondary
205.71 Closing
205.71 Transit
22.56
Primary
22.56
Secondary
22.56
Closing
22.56
Transit
47.31
47.31
47.31
47.31
11.14
11.14
11.14
11.14
21.60
21.60
21.60
21.60
174.07
174.07
174.07
174.07
46.97
46.97
46.97
46.97
34.65
34.65
34.65
34.65
69.29
69.29
69.29
69.29
68.40
68.40
68.40
68.40
111.63
111.63
111.63
111.63
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
0
0
0
0
0
0
0
110
61
67
40
0
0
0
0
0
0
0
0
35
15
31
35
0
10
35
0
0
0
0
0
50
40
70
30
10
32
187
10
0
1
53
0
Pregaba M 75
Pregaba M 75 SR
Sulbacin 4T
Sulbacin .75G
Sulbacin 1.5G
Vizyl Cap
Vizyl Sachets
Zulu 4
Zulu 8
Tri-Zulu
Izra 20
66.68
66.68
66.68
66.68
68.57
68.57
68.57
68.57
124.67
124.67
124.67
124.67
46.29
46.29
46.29
46.29
86.33
86.33
86.33
86.33
58.97
58.97
58.97
58.97
6.00
6.00
6.00
6.00
82.29
82.29
82.29
82.29
123.43
123.43
123.43
123.43
89.14
89.14
89.14
89.14
20.92
20.92
20.92
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
590
221
309
430
30
46
63
20
0
0
0
0
0
0
0
0
0
0
0
0
0
72
0
0
240
150
345
240
10
6
63
10
0
3
66
0
20
23
157
20
120
82
53
Izra 20
Izra 40
Izra L
Izra D 20
Izra D 40
Linox 600
Linox iv
LINOX OD 5T
linox xt
20.92
33.60
33.60
33.60
33.60
106.29
106.29
106.29
106.29
41.49
41.49
41.49
41.49
59.66
59.66
59.66
59.66
233.96
233.96
233.96
233.96
257.14
257.14
257.14
257.14
96.00
96.00
96.00
96.00
240.00
240.00
240.00
240.00
273.72
273.72
273.72
273.72
211.89
211.89
211.89
211.89
336.00
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
Closing
Transit
Primary
Secondary
30
110
130
130
60
0
8
64
0
40
63
128
0
240
188
68
80
0
10
57
0
0
20
97
0
0
0
0
0
0
0
0
0
0
4
27
0
90
58
72
50
10
12
56
0
Closing
Transit
Primary
Secondar
Closing
transit
REGION VALUE
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.37
1.20
2.74
0.86
0.00
0.00
0.00
0.00
0
1000
Oct'14
Nov'14
Dec'14
Jan'15
0
1000
Hq.
Jun
Jul
Aug
Sep
Oct
Nov
140
130
100
100
200
150
20
20
100
100
50
50
350
350
50
50
20
20
50
80
may
june
100
100
50
50
20
20
50
50
50
50
20
10
300
300
50
50
10
10
10
10
50
50
150
100
150
150
20
20
50
100
150
250
10
10
20
20
80
100
10
20
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PLAN
Feb'15
YTD
Mar'15 Mar'15
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.54
1.60
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
r Pri/Sec
july
0.00
0.00
0.00
0.00
PREGABA M NDC
TRACKER
Apr'15
Workarea
ABM
X-ray/Fibre scotch
activity
Workarea
ABM
BMD camps
Workarea
ABM
Workarea
May'15
No.of
camp
done
No. Rx
generate
d
No.of
camp
done
Apr'15
May'15
No.
Invested
ROI
No.
Invested
Apr'15
May'15
No.
Invested
ROI
No.
Invested
Apr'15
May'15
No.
Invested
ROI
No.
Invested
May'15
Jun'15
Jul'15
Aug'15
Sep'15
No. Rx
generated
No.of
camp
done
No. Rx
generate
d
No.of
camp
done
No. Rx
generat
ed
No.of
camp
done
No. Rx
generate
d
No.of
camp
done
No. Rx
generate
d
May'15
Jun'15
Jul'15
ROI
No.
Invested
ROI
No.
Investe
d
May'15
Jun'15
ROI
No.
Invested
ROI
May'15
Jun'15
ROI
No.
Invested
ROI
No.
Invested
ROI
No.
Invested
ROI
Aug'15
Sep'15
ROI
No.
Invested
ROI
No.
Invested
ROI
Jul'15
No.
Investe
d
Sep'15
ROI
Jul'15
No.
Investe
d
Aug'15
Aug'15
Sep'15
ROI
No.
Invested
ROI
No.
Invested
ROI
Oct'15
Nov'15
Dec'15
Jan'16
No.of
camp
done
No. Rx
generated
No.of
camp
done
No. Rx
generate
d
No.of
camp
done
No. Rx
generate
d
No.of
camp
done
No. Rx
generate
d
Oct'15
Nov'15
Dec'15
Jan'16
No.
Invested
ROI
No.
Invested
ROI
No.
Invested
ROI
No.
Invested
ROI
Oct'15
Nov'15
Dec'15
Jan'16
No.
Invested
ROI
No.
Invested
ROI
No.
Invested
ROI
No.
Invested
ROI
Oct'15
Nov'15
Dec'15
Jan'16
No.
Invested
ROI
No.
Invested
ROI
No.
Invested
ROI
No.
Invested
ROI
Feb'16
Mar'16
No.of
camp
done
No. Rx
generate
d
No.of
camp
done
Feb'16
TOTAL
No. Rx
No. Rx
No.of
generat
generated camp done
ed
Mar'16
TOTAL
No.
Invested
ROI
No.
Invested
ROI
No.
Invested
ROI
Feb'16
Mar'16
No.
Invested
ROI
No.
Invested
ROI
Feb'16
Mar'16
No.
Invested
ROI
No.
Invested
ROI
TOTAL
No.
Invested
ROI
#REF! #REF!
TOTAL
No.
Invested
ROI
#REF! #REF!